This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 92/7/732    most recent 01.RES.0000067928.83455.9Cv1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zauli, G. Articles by Secchiero, P. Search for Related Content PubMed PubMed Citation Articles by Zauli, G. Articles by Secchiero, P. Related Collections Cell biology/structural biology Cell signalling/signal transduction Growth factors/cytokines

(Circulation Research. 2003;92:732.)
© 2003 American Heart Association, Inc.

Molecular Medicine

Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand (TRAIL) Sequentially Upregulates Nitric Oxide and Prostanoid Production in Primary Human Endothelial Cells

Giorgio Zauli^*, Assunta Pandolfi^*, Arianna Gonelli, Roberta Di Pietro, Simone Guarnieri, Giovanni Ciabattoni, Rosalba Rana, Marco Vitale, Paola Secchiero

From the Department of Normal Human Morphology (G.Z., M.V.), University of Trieste, Trieste, Italy; the Department of Biomorphology (A.P., R.D.P., R.R.), "G. D’Annunzio" University of Chieti, Chieti Scalo, Chieti, Italy; the Department of Morphology and Embryology (A.G., P.S.), Human Anatomy Section, University of Ferrara, Ferrara, Italy; and the Department of Drug Sciences (G.C.), Laboratory of Cell Physiology (S.G.), "G. D’Annunzio" University of Chieti, Chieti, Italy.

Correspondence to Giorgio Zauli, MD, PhD, Department of Normal Human Morphology, University of Trieste, Via Manzoni 16, 34138 Trieste. E-mail zauli{at}units.it

Endothelial cells express tumor necrosis factor–related apoptosis-inducing ligand (TRAIL) receptors, but the function of TRAIL in endothelial cells is not completely understood. We explored the role of TRAIL in regulation of key intracellular signal pathways in endothelial cells. The addition of TRAIL to primary human endothelial cells increased phosphorylation of endothelial nitric oxide synthase (eNOS), NOS activity, and NO synthesis. Moreover, TRAIL induced cell migration and cytoskeleton reorganization in an NO-dependent manner. TRAIL did not activate the NF-B or COX-2 pathways in endothelial cells. Instead, TRAIL increased prostanoid production (PGE₂=PGI₂>TXA₂), which was preferentially inhibited by the COX-1 inhibitor SC-560. Because NO and prostanoids play a crucial role in the state of blood vessel vasodilatation and angiogenesis, our data suggest that TRAIL might play an important role in endothelial cell function.

Key Words: tumor necrosis factor–related apoptosis-inducing ligand • nitric oxide • prostanoids

This article has been cited by other articles:

				F. Corallini, F. Bossi, A. Gonelli, C. Tripodo, G. Castellino, T. E. Mollnes, F. Tedesco, L. Rizzi, F. Trotta, G. Zauli, et al. The soluble terminal complement complex (SC5b-9) up-regulates osteoprotegerin expression and release by endothelial cells: implications in rheumatoid arthritis Rheumatology, March 1, 2009; 48(3): 293 - 298. [Abstract] [Full Text] [PDF]

				M. M. Kavurma, N. Y. Tan, and M. R. Bennett Death Receptors and Their Ligands in Atherosclerosis Arterioscler Thromb Vasc Biol, October 1, 2008; 28(10): 1694 - 1702. [Abstract] [Full Text] [PDF]

				P. Secchiero and G. Zauli The Puzzling Role of TRAIL in Endothelial Cell Biology Arterioscler Thromb Vasc Biol, February 1, 2008; 28(2): e4 - e4. [Full Text] [PDF]

				P. Secchiero, F. Corallini, E. Rimondi, C. Chiaruttini, M. G. di Iasio, A. Rustighi, G. Del Sal, and G. Zauli Activation of the p53 pathway down-regulates the osteoprotegerin expression and release by vascular endothelial cells Blood, February 1, 2008; 111(3): 1287 - 1294. [Abstract] [Full Text] [PDF]

				G. Zauli, F. Corallini, F. Bossi, F. Fischetti, P. Durigutto, C. Celeghini, F. Tedesco, and P. Secchiero Osteoprotegerin increases leukocyte adhesion to endothelial cells both in vitro and in vivo Blood, July 15, 2007; 110(2): 536 - 543. [Abstract] [Full Text] [PDF]

				P. Secchiero, F. Corallini, A. Gonelli, R. Dell'Eva, M. Vitale, S. Capitani, A. Albini, and G. Zauli Antiangiogenic Activity of the MDM2 Antagonist Nutlin-3 Circ. Res., January 5, 2007; 100(1): 61 - 69. [Abstract] [Full Text] [PDF]

				P. Secchiero, F. Corallini, M. G. di Iasio, A. Gonelli, E. Barbarotto, and G. Zauli TRAIL counteracts the proadhesive activity of inflammatory cytokines in endothelial cells by down-modulating CCL8 and CXCL10 chemokine expression and release Blood, May 1, 2005; 105(9): 3413 - 3419. [Abstract] [Full Text] [PDF]

				Y. Michowitz, E. Goldstein, A. Roth, A. Afek, A. Abashidze, Y. Ben Gal, G. Keren, and J. George The involvement of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in atherosclerosis J. Am. Coll. Cardiol., April 5, 2005; 45(7): 1018 - 1024. [Abstract] [Full Text] [PDF]

				M. Tartas, P. Bouye, A. Koitka, S. Durand, Y. Gallois, J. L. Saumet, and P. Abraham Early vasodilator response to anodal current application in human is not impaired by cyclooxygenase-2 blockade Am J Physiol Heart Circ Physiol, April 1, 2005; 288(4): H1668 - H1673. [Abstract] [Full Text] [PDF]